See also this year's filing and all EDGAR filings for this company.
PDF Report 0001516551_2024_Skye_Bioscience_Inc.pdf
Logs
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001516551, Skye Bioscience Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 11,650,843 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 43,276 |
| 3 | remainder_Assets | 246,292 |
| 4 | LiabilitiesCurrent | 13,900,999 |
| 5 | LiabilitiesNoncurrent | 171,230 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 9,948,451 |
| 9 | ResearchAndDevelopmentExpense | 5,796,303 |
| 10 | remainder_Expenses | 29,843,891 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | -2,118,915 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 11,940,411 |
| 1 | Liabilities | 14,072,229 |
| 2 | Expenses | 45,588,645 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | -2,131,818 |
| 5 | NetIncome | -47,707,560 |
| 6 | ComprehensiveNetIncome | -47,707,560 |
| 7 | BaseVar | 36,860,100 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | -4.03 |
| 9 | EconomicCapitalRatio | 0.386 |
Edgar->Model Mapping
Feature Distribution
Change over Time
